FolioLanternBeta
IMVTImmunovant, Inc.

Michael Geffner

Chief Medical Officer at Immunovant, Inc., as of Oct 24, 2025Sold $49K of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
218K
shares held after the latest filing, Immunovant, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
2.6K
shares sold, past 12 months
1
days with sales
$49K
largest single day, Oct 22, 2025
1
company filed for

Share of stake sold at Immunovant, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $49K to cover taxes$49KOctNovDecJanFebMarAprMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Immunovant, Inc. (IMVT)Chief Medical OfficerJan 16, 2024Oct 24, 2025

Recent filings

The last day with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.